Protara Therapeutics CMO Leonardo Viana Nicacio resigns effective June 26, 2026

Protara Therapeutics, Inc.

Leonardo Viana Nicacio, M.D., resigned as Chief Medical Officer to pursue other opportunities.
Carla Beckham, M.D., Lead Medical Director and Head of Clinical Development, assumes his duties.
Jacqueline Zummo, Ph.D., Chief R&D Officer, will oversee the clinical development function.
Departure is effective June 26, 2026; no other officer changes disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.